Exploring Best Practices for Diagnosis and Management of Adult-Onset Stills Disease
| Overview / Abstract: |
Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease. Case studies are utilized to share the faculty’s experience in diagnosis and treatment, so as to facilitate integration into clinical practice. |
|
Expiration |
Jun 30, 2022 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
1.25 AMA PRA Category 1 Credit(s)TM, 1.25 ANCC Contact Hours |
|
Accreditation |
ACCME, ANCC |
|
Presenters / Authors / Faculty |
Petros Efthimiou, MD, FACR Olga Petryna, MD, FACR |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an independent educational grant from Novartis Pharmaceutical Corporation. |
|
Keywords / Search Terms |
Annenberg Center for Health Sciences at Eisenhower polygenic autoinflammatory syndrome canakinumab AOSD Still’s Disease Free CE CME |
|